CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Exhibits
- 4 Planned sale Chief Scientific Officer sold 50,246 shares at $25.03 ($1,257,657)
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $22.65 ($226,500)
- 4 Open-market sale Director sold 1,600 shares at $25.32 ($40,512)
- 4 Grant or award Vice President, Controller acquired 3,200 shares (grant or award)
- 144/A Insider Sale of Securities
- 4 Planned sale Chief Scientific Officer sold 125,000 shares at $26.91 ($3,363,750)
- 144 Insider Sale of Securities
- 8-K/A Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
Page 1 of 21 · 415 filings